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Previous studies have suggested an as-
sociation between subfertility and tes-
ticular cancer by using fecundity and
semen characteristics to measure fer-
tility. The occurrence of twinning in
offspring may be used to investigate
male reproductive health, because
dizygotic twinning is reduced by male
subfertility. We therefore assessed
number of children and offspring
twinning rates among 4592 Swedish
patients with testicular cancer and
12 254 control subjects. Before diag-
nosis, case patients had a decreased
number of children (for testicular
cancer, odds ratio [OR]  0.71, 95%
confidence interval [CI]  0.62 to
0.81; at least three children compared
with no children), with a lower fre-
quency of dizygotic twinning (for
unlike-sex twins, OR for the father
having testicular cancer  0.49, 95%
CI 0.22 to 1.08). The ratio of unlike-
sex to same-sex twins was 0.22 among
children of case patients and 0.66
among children of control subjects
(adjusted P  .03, two-sided Wald
test). We also found an increased oc-
currence of twinning after diagnosis,
probably attributable to treatment
for iatrogenic subfertility. Our study
strongly supports evidence of an asso-
ciation between subfertility and the
subsequent risk for testicular cancer.
[J Natl Cancer Inst 2004;96:145–7]
It has been suggested that the in-
creased occurrence of testicular cancer
and the alleged decline in male fertility
are attributable to the same exposure(s)
(1). In support of this hypothesis, obser-
vational studies have demonstrated as-
sociations between a small number of
children fathered (2) or abnormal semen
characteristics (3) and the risk of testic-
ular cancer.
Twinning rates can be used as a mea-
sure of reproductive health, because
dizygotic twinning, but not monozygotic
twinning, is reduced by male subfertility
(4). Dizygotic twinning rates can be es-
timated by the occurrence of unlike-sex
twins. Unlike the number of children,
the twinning rate has the advantage that
it is not influenced by decisions about
family size.
We therefore assessed the number of
children and unlike-sex twins fathered
by men who subsequently developed
testicular cancer. These two variables
are independent indicators of fertility,
and they permitted us to evaluate the
previously reported association between
low fecundity and the risk of testicular
cancer.
We used the Swedish Cancer Regis-
try to identify patients with germ-cell
testicular cancer [International Classifi-
cation of Diseases, 7th Revision (ICD-
7), code 178 (5)] who were diagnosed
between January 1, 1958, and December
31, 1998; were born after 1915; and
were 18–54 years old at diagnosis. Male
control subjects, matched on year of
birth, age, and county, were identified
through the Swedish Register of Popu-
lation and Population Changes. We used
the Swedish Multi-Generation Registry,
which lists known relations between
first-degree relatives for citizens born
after 1931 who were alive in 1961 (6), to
obtain information on date of birth and
sex of offspring fathered between Janu-
ary 1, 1932, and February 28, 2000, by
case patients and control subjects. Infor-
mation on fathers and siblings was used
to exclude case patients (1.6%) with fa-
milial testicular cancer. Information in-
cluded in the Swedish Register of Pop-
ulation and Population Changes allowed
exclusion of subjects with incomplete
follow-up because of migration. The
study was approved by the Ethics Com-
mittee at the Karolinska Institutet.
We identified 4592 case patients and
12 254 control subjects. Two periods
were considered: 1) up to 6 months be-
fore diagnosis and 2) at least 2 years
after diagnosis. The date of diagnosis for
each case patient was used as the time
reference for the corresponding control
subjects. Analyses on number of chil-
dren were restricted to the first period,
because subjects’ date of death was un-
known. During both periods, 5518 chil-
dren were fathered by case patients and
18 038 children were fathered by control
subjects. Multiple deliveries were iden-
tified as siblings born in the same 3-day
interval who shared the same father. In
total, there were 238 multiple births, in-
cluding one set of triplets among the
children of case patients and two sets of
triplets among the children of control
subjects. Ninety-eight (41%) of the 238
multiple births were unlike-sex twins.
Odds ratios (ORs) and 95% confi-
dence intervals (CIs) for testicular can-
cer according to number of children
were estimated with unconditional lo-
gistic regression (7). Among children of
case patients and control subjects, we
estimated the odds ratio for being
unlike-sex twins according to the case–
control status of the father. In addition,
we calculated the ratio of unlike-sex to
same-sex twins, which is an attenuated
measure of the dizygotic/monozygotic
twin ratio, because dizygotic twins can
be of the same sex. Because in vitro
fertilization began to influence twinning
rates in Sweden in the 1990s (8), we
performed further analyses stratifying
by year of birth of offspring, with 1990
as the threshold. Finally, because a de-
creased proportion of males was previ-
ously found among the offspring of pa-
tients with testicular cancer (9), but not
among the offspring of subfertile men
(10), we calculated and compared the
sex ratio among singletons born to case
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patients and control subjects. All statis-
tical tests were two-sided.
Table 1 summarizes basic character-
istics of the study subjects. The risk of
testicular cancer decreased monotoni-
cally with increasing number of children
fathered before diagnosis (Table 2; OR
for testicular cancer  0.71, 95% CI 
0.62 to 0.81, for at least three children
compared with no children). There were
no major differences between case pa-
tients with seminoma and case patients
with nonseminoma, the two major histo-
logic types of testicular cancer, and lag
times of 4 or 10 years before diagnosis
changed risk estimates only marginally.
Before diagnosis, offspring of case
patients were less likely to be unlike-sex
twins than offspring of control subjects
(for unlike-sex twins, OR for the father
having testicular cancer  0.49, 95% CI
 0.22 to 1.08; Table 3). The ratio of
unlike-sex to same-sex twins was 0.22
among children of case patients and 0.66
among children of control subjects (ad-
justed P for difference  .03, two-sided
Wald test). Changing the lag time before
diagnosis from 6 months to 4 years did
not substantially alter the estimates (for
unlike-sex twins, OR for the father hav-
ing testicular cancer  0.52, 95% CI 
0.15 to 1.77, from three and 17 sets of
twins among children of case patients
and control subjects, respectively). After
1989, the probability of being unlike-sex
twins increased among offspring of case
patients.
Analyses of the period after diagnosis
revealed that children of case patients
had a higher probability of being unlike-
sex twins. The association was stronger
among children born after 1989. The
ratio of unlike-sex twins to same-sex
twins was similar among children of
case patients (ratio  1.23) and among
children of control subjects (ratio 
1.06).
Singleton sex ratio was not altered
before diagnosis of testicular cancer
(percentage of males among children of
case patients  51.1% and that among
children of control subjects  50.9%;
P  .85), and it was slightly reduced
after diagnosis (49.2% and 51.8%, re-
spectively; P  .14). In the latter anal-
ysis, we had an 80% power to detect a
statistically significant reduction in the
proportion of male children ( level 
.05), if the male offspring proportion
was 47% or less.
Subfertility, usually defined as at
least 1 year of unprotected intercourse
without conception (11), may decrease
the probability of having a child and of
fathering unlike-sex twins. Our findings
therefore indicate that fertility is im-
paired among men who will subse-
quently develop testicular cancer. Most
causes of male subfertility are unknown,
but genetic disorders, congenital dis-
eases (including cryptorchidism), life-
style factors (such as smoking and nu-
trition), medical procedures (including
radiation and chemotherapy), and envi-
ronmental exposures are, or may be, im-
plicated in its etiology (12,13).
An association between the number
of children and the risk of testicular can-
cer has been reported previously
(2,3,9,14), whereas our findings on
twinning rates are novel. A decreased
occurrence of dizygotic twinning is as-
sociated with male subfertility because
of the decreased ability of sperm to fer-
tilize oocytes and to sustain their embry-
onic development. Furthermore, the dif-
ference in frequency of twinning before
and after 1990, when use of in vitro
fertilization techniques became common
in Sweden, suggests that subfertility
problems among future testicular cancer
patients may, to some extent, have re-
sulted in assisted reproduction. In vitro
fertilization is a strong iatrogenic cause
of twinning, mostly, but not exclusively,
of the dizygotic type (15).
Because testicular cancer occurs at
young ages, subfertility after treatment
is of concern for many patients, irre-
spective of its being iatrogenic or al-
ready present at the time of cancer diag-
nosis (16,17). Our findings of a higher
likelihood of twinning among patients
with a history of testicular cancer prob-
ably reflect their need for assisted repro-
duction, including sperm banking fol-
lowed by in vitro fertilization or
intracytoplasmatic sperm injection tech-
niques (18).
Table 1. Basic characteristics of study subjects (Sweden, 1958–1998)
Characteristic
No. of case
patients (%)*
No. of control
subjects (%)*
Year of birth
Before 1945 1667 (36) 4108 (34)
1945–1954 1217 (27) 3353 (27)
1955–1964 1068 (23) 3021 (25)
1965–1974 586 (13) 1635 (13)
1975 or after 54 (1) 137 (1)
Study area
Largest Swedish cities† 1843 (40) 4895 (40)
Northern Sweden 696 (15) 1948 (16)
Southern Sweden 2053 (45) 5411 (44)
*Age at diagnosis among case patients was 33.7  8.58 years (mean  standard deviation), and age
at recruitment among control subjects was 33.5  8.51 years.
†Largest Swedish cities include Stockholm, Malmö, and Göteborg.
Table 2. Association between number of children and risk for germ-cell testicular cancer (Sweden, 1958–1998)
No. of
children
6 months before diagnosis* 4 years before diagnosis* 10 years before diagnosis*
No. of case
patients OR (95% CI)
No. of case
patients OR (95% CI)
No. of case
patients OR (95% CI)
0 2331 1.00 (referent) 2760 1.00 (referent) 3417 1.00 (referent)
1 802 0.84 (0.76 to 0.93) 694 0.81 (0.73 to 0.90) 544 0.88 (0.78 to 0.99)
2 997 0.77 (0.70 to 0.85) 797 0.78 (0.70 to 0.87) 464 0.80 (0.70 to 0.91)
3 462 0.71 (0.62 to 0.81) 341 0.72 (0.62 to 0.83) 167 0.69 (0.57 to 0.85)
*The number of case patients and the odds ratio (OR) adjusted for year of birth, age at diagnosis/recruitment (2-year age groups), and study area (three
categories the largest Swedish cities [Stockholm, Göteborg, and Malmö], northern Sweden, and southern Sweden) were shown. For all time groups, P for linear
trend .001, two-sided Wald test. CI  confidence interval.
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To our knowledge, this is the largest
study to investigate fertility before the
diagnosis of testicular cancer. The use of
population-based registries permitted us
to decrease the likelihood of information
bias. We did not have information on
some possible confounders, such as
socio-economic class or history of cryp-
torchidism, but the consistency of our
results on the two independent indica-
tors of fertility decreases the chance of
spurious associations. Maternal parity
and age influence dizygotic twinning
rates (19). We adjusted for the former
variable in the analyses and used pater-
nal age as a proxy for the latter variable.
In conclusion, our study strongly
supports an association between male
subfertility and the risk of subsequent
testicular cancer, possibly indicating
common etiologic risk factors, probably
acting early in life, that interfere with
spermatogenesis resulting in subfertility
and/or testicular cancer.
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Table 3. Association of unlike-sex birth with paternal germ-cell testicular cancer (Sweden, 1958–1998)
Type of delivery Case patients Control subjects
Odds ratio (95% confidence interval)*
Entire period Born before 1990 Born in 1990 or after
Before diagnosis (6 mo)
Singleton, No. 4316 12 542 1.00 (referent) 1.00 (referent) 1.00 (referent)
Unlike-sex twins, No. 7 42 0.49 (0.22 to 1.08) 0.40 (0.16 to 1.01) 1.08 (0.21 to 5.66)
Frequency, No. per 1000 births 1.6 3.3
After diagnosis (2 y)
Singleton, No. 1065 5154 1.00 (referent) 1.00 (referent) 1.00 (referent)
Unlike-sex twins, No. 16 33 2.03 (1.11 to 3.73) 1.53 (0.42 to 5.55) 2.10 (1.04 to 4.25)
Frequency, No. per 1000 births† 14.6 6.3
*Odds ratios were adjusted for year of birth, paternal age (each 5-year increase), and number of older siblings (0 or 1, for the period before diagnosis; 0,
1, 2, or 3, for the period after diagnosis).
†Twin births are included in the denominator of the proportion.
Journal of the National Cancer Institute, Vol. 96, No. 2, January 21, 2004 BRIEF COMMUNICATIONS 147
 at U
ni Torino D
ip Sanità Pubblica M
icrobiologia on A
pril 3, 2012
http://jnci.oxfordjournals.org/
D
ow
nloaded from
 
